Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
   Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
   
  May 11, 2023
  Tickers 
   OPTHF
  
  
  From Benzinga
 
   Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
   
  
  
  May 11, 2023
  From Benzinga
 
   Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
   
  May 10, 2023
  Tickers 
   HUGE
  
  
  From Benzinga
 
   Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
   
  May 09, 2023
  Tickers 
   CYBN
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 
   Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
   
  
  
  May 08, 2023
  From Benzinga
 
   Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings
   
  May 07, 2023
  Tickers 
   COPHF
  
  
  From Benzinga
 From Benzinga
 
   NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs
   
  
  May 05, 2023
  From Benzinga
 
   Washington State County Decriminalizes Psychedelics, Gov. Calls For Special Session On Drug Policy
   
  
  May 04, 2023
  From Benzinga
 
   International IP Claims On Novel Psychedelic Fungi Biomass Manufacturing Gets Prelim Acceptance
   
  
  May 03, 2023
  From Benzinga
 
   Colorado's Rapidly-Progressing Measure For Legal Psychedelics Regulation Heads To Gov.'s Desk
   
  
  May 03, 2023
  From Benzinga
 
   Psychedelics Reform Update: Arizona's MDMA Gets Gov's Signature, California, Minnesota & Missouri's Progress
   
  
  May 02, 2023
  From Benzinga
 
   EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations
   
  
  
  May 02, 2023
  From Benzinga
 
   EXCLUSIVE: Ibogaine Therapy Co. Bienstar On Successful Addiction Treatment, Global Market & Future Prospects
   
  
  April 27, 2023
  From Benzinga
 
   Colorado Takes Another Step In Psychedelics Regulation As Amended Bill Receives Approval
   
  
  April 26, 2023
  From Benzinga
 
   Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued
   
  
  April 26, 2023
  From Benzinga
 
   This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection
   
  April 26, 2023
  Tickers 
   MSSTF
  
  
  From Benzinga
 From Benzinga
 
   Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
   
  
  
  April 24, 2023
  From Benzinga
 
   Psychedelics Reform Update: NC's $5M Grant, WA's Pilot Program, Plus Rescheduling Proposals
   
  
  April 21, 2023
  From Benzinga
 
   Psychedelics Therapy For Teens, Elders, And Borderline Disorder Patients: Here Are The Latest Findings
   
  
  April 21, 2023
  From Benzinga
 
   Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off
   
  April 20, 2023
  Tickers 
   CMND
  
  
  From Benzinga
 
   Psyched Business: Lobe Buys Rare Disease Treatment, Plus Healing CREI And Heally Team Up
   
  April 20, 2023
  Tickers 
   LOBEF
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.